m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1

Abstract

Background Long noncoding RNAs (lncRNAs) have emerged as critical players in cancer progression, but their functions in colorectal cancer (CRC) metastasis have not been systematically clarified. Methods lncRNA expression profiles in matched normal and CRC tissue were checked using microarray analysis. The biological roles of a novel lncRNA, namely RP11-138 J23.1 (RP11), in development of CRC were checked both in vitro and in vivo. Its association with clinical progression of CRC was further analyzed. Results RP11 was highly expressed in CRC tissues, and its expression increased with CRC stage in patients. RP11 positively regulated the migration, invasion and epithelial mesenchymal transition (EMT) of CRC cells in vitro and enhanced liver metastasis in vivo. Post-translational upregulation of Zeb1, an EMT-related transcription factor, was essential for RP11-induced cell dissemination. Mechanistically, the RP11/hnRNPA2B1/mRNA complex accelerated the mRNA degradation of two E3 ligases, Siah1 and Fbxo45, and subsequently prevented the proteasomal degradation of Zeb1. m 6 A methylation was involved in the upregulation of RP11 by increasing its nuclear accumulation. Clinical analysis showed that m 6 A can regulate the expression of RP11, further, RP11 regulated Siah1-Fbxo45/Zeb1 was involved in the development of CRC. Conclusions m 6 A-induced lncRNA RP11 can trigger the dissemination of CRC cells via post-translational upregulation of Zeb1. Considering the high and specific levels of RP11 in CRC tissues, our present study paves the way for further investigations of RP11 as a predictive biomarker or therapeutic target for CRC. Electronic supplementary material The online version of this article (10.1186/s12943-019-1014-2) contains supplementary material, which is available to authorized users.

LINC00511 contributes to glioblastoma tumorigenesis and epithelial‐mesenchymal transition via LINC00511/miR‐524‐5p/YB1/ZEB1 positive feedback loop

“…13,14,37 In this study, we found that ZEB1 could act as a transcription factor that binds LINC00511 in its promoter region to positively induce its expression, which completes the LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop. 31 ZEB1 acts as a classical transcriptional inducer of EMT in many cancers.…”

The how and why of lncRNA function: An innate immune perspective

“…A study by Winkler et al showed that m6A modification controls the innate immune response to infection by targeting type I interferons [267]. A few recent studies have shown that lncRNAs do have RNA modifications such as MALAT1 containing m6A modifications [268,269], HOTAIR containing m5C and m6A [270,271] and XIST containing ψ, m6A and m5C modifications [269]. A study by Zhou et al showed that the RNA modification, m6A, acts as a structural 'switch' in Malat1.…”

Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A‐dependent manner

“…[3][4][5] mRNA modifications represent another layer of epigenetic regulation of gene expression, which has been termed 'RNA epigenetics' or 'epitranscriptomics'. Among these, m6A modification is the most prevalent one in eukaryotes, 6 which occurs in mammalian mRNAs, 7,8 long noncoding RNAs, 9 micro RNAs, 10,11 involving in many RNA functions such as mRNA stability, 7 splicing, 12 transport, 13 localization and translation, 8,14 primary microRNA processing 10 and RNA-protein interactions. 15 The levels of m6A modification in mRNAs were usually controlled by so-called 'reader', 'writer' and 'eraser'.…”